Nephrocare Subsidiary Acquires Dialysis Center Assets for PhP 80 Million
Nephrocare Health Services Limited's overseas subsidiary has completed an asset acquisition, securing a dialysis center located in the Philippines. The transaction involves the purchase of identified assets from Pag-Asa Dialysis And Diagnostic Center.The agreement was formalized on June 22, 2026, under an Asset Transfer Agreement (ATA). Nephrocare Health Care Services, Philippines Inc., which is an overseas step-down wholly-owned subsidiary of Nephrocare Health Services Limited, acted as the purchaser in the deal. The acquisition relates to a dialysis center situated at Magsaysay St., Poblacion, Ipil, Zamboanga Sibugay, Philippines.
The total consideration for the identified assets amounts to PhP 80,640,000.
Key details regarding the asset transfer transaction are outlined below:
| Particulars | Details |
|---|---|
| Purchaser | Nephrocare Health Care Services, Philippines Inc. (an overseas step-down wholly-owned subsidiary of the Company) |
| Seller | Pag-Asa Dialysis And Diagnostic Center |
| Purpose of Agreement | Acquisition of the dialysis center assets pursuant to the Asset Transfer Agreement |
| Transaction Size | PhP 80,640,000 |
| Relationship Status | The Purchaser is a wholly-owned subsidiary of Nephrocare Health Services Limited. The Seller is not related to the company or its group. |
The transaction involves no special rights, as stipulated in the agreement, and was confirmed not to be a related party transaction.
NEPHROPLUS Stock Price Movement
Shares of Nephrocare Health Services Limited shed value today, settling at ₹695.00 after slipping by 4.07% from the previous close. The stock traded during the session with a high of ₹726.45 and low of ₹680, amidst a volume of 335,089 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.